Portland-based biotech company Araceli Biosciences raised $11.2 million in new funding to fuel the expansion of its ...

A team of scientists has uncovered the mechanism of cellular uptake for large and polar drugs and devised a novel strategy to ...

Phenotypic screening has re-emerged as a powerful strategy for identifying drugs based on their observable effects. Discover ...

GenAI offers a realistic path forward in tackling previously undruggable targets, with the potential to reshape the entire ...

In a study published in Angewandte Chemie International Edition, a research team integrated activity-based protein profiling ...

Breakthrough research could make any IV drug able to be taken orally for a range of hard-to-treat cancers and other diseases, and redefine how medicines are designed, evaluated and delivered.

Researchers have made a major breakthrough that could transform IV medications into oral treatments for diseases like brain ...

Debiopharm, Oncodesign Services announce license agreement for use of AbYlink technology for pre-clinical services: Martigny, Switzerland Saturday, April 26, 2025, 17:00 Hrs [IST] ...

Watch techUK's webinar "How can quantum unlock benefits in life sciences and drug discovery?" below, as part of the quantum ...

Roche’s Genentech is betting on the Flagship Pioneering–founded company’s discovery platform called DECODE to find new ...

Clinical trial success rates are very low, with up to 95% not succeeding, and a wide range of disease states remains ...